Skip to content
10-K/A

Annual Report

Biostax Corp.

0001493152-24-026260

← back to feed
Filed
Jul 5, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jun 4, 2024 83.74M sh
Shares Diluted restated FY 2023 · Dec 31, 2023 83.51M sh
Shares Diluted FY 2023 · Dec 31, 2022 36.29M sh
Operating Cash Flow restated FY 2023 · Dec 31, 2023 −$408.03K
Operating Cash Flow FY 2023 · Dec 31, 2022 −$581.82K
Cash And Equivalents FY 2023 · Dec 31, 2023 $29.79K
Cash And Equivalents FY 2023 · Dec 31, 2022 $150.49K
Stockholders Equity restated FY 2023 · Dec 31, 2023 −$4.53M
Stockholders Equity FY 2023 · Dec 31, 2022 −$2.51M
Stockholders Equity FY 2023 · Dec 31, 2021 −$7.95M
Current Liabilities restated FY 2023 · Dec 31, 2023 $4.56M
Current Liabilities FY 2023 · Dec 31, 2022 $3.48M
Total Liabilities restated FY 2023 · Dec 31, 2023 $4.56M
Total Liabilities FY 2023 · Dec 31, 2022 $3.48M
Current Assets FY 2023 · Dec 31, 2023 $29.79K
Current Assets FY 2023 · Dec 31, 2022 $150.49K
Total Assets restated FY 2023 · Dec 31, 2023 $35.29K
Total Assets FY 2023 · Dec 31, 2022 $963.72K
Eps Diluted restated FY 2023 · Dec 31, 2023 −$0.03
Eps Diluted FY 2023 · Dec 31, 2022 −$0.10
Eps Basic restated FY 2023 · Dec 31, 2023 −$0.03
Eps Basic FY 2023 · Dec 31, 2022 −$0.10
Sga Expense FY 2023 · Dec 31, 2023 $957.11K
Sga Expense FY 2023 · Dec 31, 2022 $1.15M
Rd Expense FY 2023 · Dec 31, 2023 $473.53K
Rd Expense FY 2023 · Dec 31, 2022 $14.24K
Net Income restated FY 2023 · Dec 31, 2023 −$2.36M
Net Income FY 2023 · Dec 31, 2022 −$3.54M
Operating Income FY 2023 · Dec 31, 2023 −$1.48M
Operating Income FY 2023 · Dec 31, 2022 −$1.16M